CCIA
Campbell & Co Investment Adviser’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-50,900
| Closed | -$1.58M | – | 1423 |
|
|
2025
Q1 | $1.58M | Sell |
50,900
-44,320
| -47% | -$1.38M | 0.12% | 260 |
|
|
2024
Q4 | $2.43M | Buy |
95,220
+18,006
| +23% | +$459K | 0.19% | 137 |
|
|
2024
Q3 | $2.18M | Buy |
77,214
+15,816
| +26% | +$447K | 0.16% | 166 |
|
|
2024
Q2 | $1.62M | Buy |
61,398
+36,807
| +150% | +$971K | 0.14% | 218 |
|
|
2024
Q1 | $747K | Buy |
24,591
+11,726
| +91% | +$356K | 0.06% | 521 |
|
|
2023
Q4 | $361K | Buy |
+12,865
| New | +$361K | 0.03% | 850 |
|
|
2023
Q3 | – | Sell |
-9,970
| Closed | -$306K | – | 1157 |
|
|
2023
Q2 | $306K | Buy |
+9,970
| New | +$306K | 0.05% | 656 |
|